Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 802 results for "alexion pharmaceuticals"

Alexion Pharmaceuticals Moves Up In Market Cap Rank, Passing Norfolk Southern
Forbes.com

Alexion Reports Validation of Marketing Authorization Applicat...

Alexion Pharmaceuticals said that the Marketing Authorization Application for asfotase alfa, an investigational targeted enzyme replacement therapy for the treatment of hypophosphatasia, has been validated and granted accelerated assessment by the ... Individual.com, 1 day ago
[x]  

74 images for alexion pharmaceuticals

American Banking News, 1 week ago
New Haven Independent, 6 days ago
Forbes.com, 1 week ago
Forbes.com, 1 week ago
ABC News 4 Charleston, 2 days ago
American Banking News, 1 month ago
ETF Channel, 1 week ago
State Of The Markets.com, 3 weeks ago
I Stock Analyst, 3 weeks ago
Daily Finance, 1 month ago

Alexion Posts Second Quarter 2014 Earnings

Alexion Pharmaceuticals reported financial results for the three and six months ended June 30. According to its release on July 24, the Company reported net product sales of Soliris of $512.5 million in the second quarter of 2014, an increase of 38 ...
 Individual.com1 day ago

Alexion Pharmaceuticals (ALXN) Trading Near $170.26 Resistance Level

For a hedged play on Alexion Pharmaceuticals Inc (http://www.marketintelligencecenter.com/symbol/ALXN"ALXN) MarketIntelligenceCenter.comaEUR(TM)s patented trade-picking algorithms selected a Sep. '14 $160.00 covered call for a net debit in the ...
 Individual.com2 days ago Alexion Pharmaceuticals (ALXN) Showing Bullish Technicals With Resistance At $170.53  PredictWallStreet3 days ago Potential Alexion Pharmaceuticals (ALXN) Trade Has 9.18% Downside Protection  Individual.com1 week ago
[x]  

Alexion Pharmaceuticals Set to Possibly Rebound After Yesterday's Selloff of 2.57%

Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $160.38 to a high of $167.20. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $163.02 on volume of 1.6 million ...
 Individual.com3 days ago Alexion Pharmaceuticals Trading Lower on 1.5x Above-Average Volume (ALXN)  Individual.com1 week ago SmarTrend Watching for Potential Pullback in Shares of Alexion Pharmaceuticals After 1.31% Gain  Individual.com1 week ago Alexion Pharmaceuticals Falls 2.34% on Heavy Volume: Watch For Potential Rebound  Comtex SmarTrend2 weeks ago
American Banking News

Alexion Pharmaceuticals beats by $0.05, beats on revenue

06:36 ET | About: Alexion Pharmaceuticals, Inc. (ALXN) Alexion Pharmaceuticals (NASDAQ:ALXN): Q2 EPS of $1.12 beats by $0.05. Revenue of $512.49M (+38.5% Y/Y) beats
 Seeking Alpha1 week ago Alexion Pharmaceuticals EPS Estimates More Optimistic Over Past Month  Forbes.com1 week ago Alexion Pharmaceuticals (ALXN) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS  American Banking News1 week ago Alexion Pharmaceutical To Beat Earnings Again  Bidness Etc1 week ago

Alexion Pharmaceuticals Q2 earnings jump

Alexion Pharmaceuticals (ALXN), a manufacturer of life-transforming therapeutic products, has recorded a 73.64 percent surge in profit for the quarter ended Jun. 30, 2014, on the back of strong sales growth and expansion margins. The company earned ...
 MyIris3 days ago
[x]  

Celgene, Alexion Beat Estimates, But Biotechs Fall

Big-cap biotechs Celgene and Alexion Pharmaceuticals modestly beat Q2 estimates and raised their guidance early Thursday, but their shares tumbled as Wall Street seemed to turn against the sector. Celgene 's (NASDAQ: CELG ) Q2 earnings rose 18% ...
 Investor's Business Daily1 week ago Celgene, Alexion Earnings Top Street, But Stocks Fall  Investor's Business Daily1 week ago Video: Celgene, Alexion Earnings Top, But Stocks Fall  Investor's Business Daily1 week ago Biogen, Gilead Earnings Crush Q2 Estimates  Yahoo! Finance1 week ago

Alexion Profits Up 38% From A Year Earlier [The Hartford Courant :: ]

July 25--Alexion Pharmaceuticals Alexion Pharmaceuticals, the highly successful biotech company headquartered in Cheshire, grew profits by more than $70 million in the second quarter of 2014 compared with the same period a year earlier, as more ...
 BusinessWeek6 days ago
[x]  

ALEXION PHARMACEUTICALS INC - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

A (Edgar Glimpses Via Acquire Media NewsEdge) Note Regarding Forward-Looking Statements This quarterly report on Form 10-Q contains forward-looking statements that have been made pursuant to the provisions of the Private Securities Litigation Reform ...
 TMC Net6 days ago

Q2 2014 Alexion Pharmaceuticals Earnings Conference Call (Webcast)

The following audio is from a conference call that will begin on July 24, 2014 at 10:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Source: We cover over 5K calls/quarter You will now ...
 Seeking Alpha1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less